Mumbai-based speciality chemicals firm, Platinum Industries, is entering the life sciences sector through a wholly owned subsidiary, Rivadu Lifesciences Pvt. Ltd., and has appointed Dr. Abhigyan Upadhyay to lead the new business.
Dr. Upadhyay brings over 25 years of experience across life sciences, regulated manufacturing, diagnostics, and research environments, and has been involved in clinical trials and research initiatives during the Covid-19 pandemic.
The company will initially focus on APIs and intermediates, targeting markets in India, the Middle East, the US, Europe, and Asia. Platinum Industries said the move aligns with rising global demand for quality-certified pharmaceutical supply chain partners and India's growing role in high-value life sciences.
Platinum Industries currently makes specialty chemicals for the plastics, paints, and coatings industries, and sells into more than 30 countries.
Commenting on the development, Mr. Krishna Dushyant Rana, Chairman & Managing Director, Platinum Industries, said, “Our entry into life sciences reflects a deliberate step towards advancing our core philosophy of responsible chemistry into areas that have a direct and meaningful impact on human health. We see this as a long-term, innovation-led opportunity, and Dr. Upadhyay’s experience brings the strategic depth and execution capability required to build this business in a disciplined and phased manner.”


22 May, 2026 15:43:03 IST 

















